有乳腺癌个人史女性的MRI监测:简略方案与全诊断方案的比较
该回顾性研究分析了1312例乳腺癌术后筛查MRI,比较简略方案(AB-MRI)与全诊断方案(FDP-MRI)对复发乳腺癌的诊断性能。AB-MRI敏感度70%、FDP-MRI 100%,两者特异度、准确率及AUC相近,AB-MRI假阳性病例更少,作者认为AB-MRI是可靠的替代方案且采集时间更短。
要点
- AB-MRI敏感度70%、FDP-MRI 100%,两者阴性预测值分别为99.5%和100%。
- AB-MRI特异度98.0%高于FDP-MRI 96.9%,阳性预测值35.0%高于23.1%。
- AB-MRI的AUC为0.840,FDP-MRI为0.985,前者假阳性病例更少。
关键影像表现/征象
- 共检出13例复发肿瘤(1.0%),包括8例浸润癌、2例原位癌和3例转移性淋巴结。
诊断标准与关键数值
- AB-MRI与FDP-MRI的敏感度分别为70%和100%,阴性预测值分别为99.5%和100%。
- AB-MRI与FDP-MRI的特异度分别为98.0%和96.9%,阳性预测值分别为35.0%和23.1%。
- AB-MRI与FDP-MRI的准确率分别为97.6%和97.0%,AUC分别为0.840和0.985。
- AB-MRI包括T2加权扫描及动态增强成像,含1次增强前和2次增强后扫描。
临床应用与阅片要点
- 作者认为AB-MRI可作为一种可靠的替代方案,诊断性能相似且MRI采集时间更短。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the diagnostic performance of breast MRI with abbreviated protocol (AB-MRI) and full ddiagnostic protocol (FDP-MRI) for surveillance of females with a personal history of breast cancer.
METHODS: In this retrospective study, we analyzed the outcomes of total 1312 post-operative screening breast MRI matched from 1045 AB-MRI and 677 FDP-MRI, which had histologic confirmation for suspicious MRI findings or 1 year negative follow-up images. This study was approved by the institutional review board and informed patient consent was waved. AB-MRI consists of T2 weighted scanning and dynamic contrast-enhanced imaging including one pre-contrast and two post-contrast scans. We compared the diagnostic performance for recurrent breast cancer in terms of sensitivity, specificity, positive-predictive value, negative-predictive value, and accuracy and area under the curve between the screening AB-MRI and FDP-MRI.
RESULTS: Overall, 13 recurrent tumors among 1312 post-operative cases screened with breast MRI (1.0%) were detected including 8 invasive cancer, 2 cases of in situ cancer, and 3 cases of metastatic lymph nodes. The sensitivity and negative predictive value were 70 vs 100 and 99.5% vs 100% in AB-MRI and FDP-MRI. Specificity, positive predictive value, accuracy, and area under the curve of AB-MRI and FDP-MRI were 98.0% vs 96.9%, 35.0% vs 23.1%, 97.6% vs 97.0%, and 0.840 vs 0.985, respectively.
CONCLUSION: The performance of AB-MRI was comparable to that of FDP-MRI in detecting recurrent breast cancer and decreased false positive cases.
ADVANCES IN KNOWLEDGE: AB-MRI provides a reliable alternative with similar diagnostic performance and shorter MRI acquisition time.
引用
- Park KW, Han SB, Han BK, et al. MRI surveillance for women with a personal history of breast cancer: comparison between abbreviated and full diagnostic protocol. Br J Radiol. 2020. PMID: 31868524. doi:10.1259/bjr.20190733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。